You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

preoperative pembrolizumab with concurrent chemoradiotherapy

Showing 1 - 25 of 8,460
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Rectal Cancer Trial in Chongqing (CIETAI-R)

Recruiting
  • Rectal Cancer
  • CIETAI-R
  • Chongqing, Chongqing, China
    Daping Hospital, Third Military Medical University
Jul 21, 2023

Esophageal Squamous Cell Carcinoma Trial in Taipei City (Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Taipei City, Taiwan
    National Taiwan University Hospital
Jun 5, 2022

Squamous Cell Esophageal Carcinoma, Esophageal Cancer, Oesophageal Cancer Trial in Guangzhou (drug, radiation, procedure)

Recruiting
  • Squamous Cell Esophageal Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 11, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Pembrolizumab Injection)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Pembrolizumab Injection
  • Shanghai, Shanghai, China
  • +1 more
Aug 29, 2021

Lymph Node Metastasis, Cancer of Rectum and Anus, Oxaliplatin Trial in Beijing (Experimental: FOLFOXIRI and Lateral lymph node

Enrolling by invitation
  • Lymph Node Metastasis
  • +6 more
  • Experimental: FOLFOXIRI and Lateral lymph node dissection
  • Preoperative long-term concurrent chemoradiotherapy and Lateral lymph node dissection
  • Beijing, Beijing, China
    Cancer Hospital, Chinese Academy of Medical Sciences, Peking Uni
Sep 15, 2023

Gastroesophageal Junction Adenocarcinoma Trial in Shijiazhuang (Oxaliplatin; Capecitabine, Oxaliplatin; Capecitabine; concurrent

Completed
  • Gastroesophageal Junction Adenocarcinoma
  • Oxaliplatin; Capecitabine
  • Oxaliplatin; Capecitabine; concurrent radiotherapy
  • Shijiazhuang, Hebei, China
    Department of General Surgery
Feb 4, 2022

NSCLC Trial in Worldwide (biological, drug, radiation)

Recruiting
  • Carcinoma, Non-Small-Cell Lung
  • pembrolizumab/vibostolimab
  • +7 more
  • Hollywood, Florida
  • +29 more
Aug 22, 2022

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (drug, procedure, radiation)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab-paclitaxel, cisplatin and Pembrolizumab combination
  • +3 more
  • Guangzhou, Guangdong, China
    Guangdong Provincial People's Hospital
Feb 28, 2022

Extensive Stage Small Cell Lung Carcinoma, Limited Stage Small Cell Lung Carcinoma, Neuroendocrine Tumor Trial in Houston (drug,

Active, not recruiting
  • Extensive Stage Small Cell Lung Carcinoma
  • +2 more
  • Houston, Texas
    M D Anderson Cancer Center
Feb 2, 2022

Esophageal Squamous Cell Carcinoma Trial in Beijing (Pembrolizumab)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Beijing, Beijing, China
    Cancer Institute and Hospital, Chinese Academy of Medical Scienc
Sep 13, 2022

Stomach Tumors, Esophagogastric Junction Disorder, Neoadjuvant Therapy Trial in Shanghai (drug, radiation, procedure)

Recruiting
  • Stomach Neoplasms
  • +7 more
  • Shanghai, China
    Fudan University Shanghai Cancer Center
Dec 3, 2021

Locally Advanced Esophageal and Gastric Cancers (EGC) Trial in Durham (Pembrolizumab)

Active, not recruiting
  • Locally Advanced Esophageal and Gastric Cancers (EGC)
  • Durham, North Carolina
    Duke Cancer Center
Dec 7, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Pembrolizumab)

Unknown status
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, Shanghai, China
    Ruijin Hospital, Shanghai JiaoTong University School of Medicine
May 31, 2020

Gastric Cardia Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Stage IB Gastric Cancer AJCC v7 Trial in Phoenix,

Active, not recruiting
  • Gastric Cardia Adenocarcinoma
  • +7 more
  • Phoenix, Arizona
  • +1 more
May 12, 2022

Uterine Cervical Tumors Trial in Worldwide (biological, drug, radiation)

Recruiting
  • Uterine Cervical Neoplasms
  • Pembrolizumab
  • +4 more
  • Los Angeles, California
  • +171 more
Apr 7, 2022

Esophageal Cancer, Intensity-modulated Radiation Therapy, Concurrent Chemoradiotherapy Trial in Beijing (rhTPO)

Not yet recruiting
  • Esophageal Cancer
  • +3 more
  • Beijing, Beijing, China
    Department of Radiation Oncology, Cancer Institute and Hospital,
Jul 12, 2023

Pancreatic Carcinoma Trial in Nanjing (Toripalimab, Gemcitabine, Nab paclitaxel)

Not yet recruiting
  • Pancreatic Carcinoma
  • Nanjing, Jiangsu, China
    The Affiliated Nanjing Drum Tower Hospital of Nanjing University
Oct 6, 2023

Head and Neck Squamous Cell Carcinoma Trial in Guangzhou (Nab paclitaxel, Carboplatin, adelbelimumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • Nab paclitaxel
  • +2 more
  • Guangzhou, Guangdong, China
    Sun Yat-sen Memorial Hospital
Aug 24, 2023

Head and Neck Squamous Cell Carcinoma Trial (Pembrolizumab, Cisplatin, Paclitaxel-albumin)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Oct 25, 2023

Locally Advanced Rectal Cancer Trial in Beijing (Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor), Long-course

Recruiting
  • Locally Advanced Rectal Cancer
  • Long-course chemoradiation, with Tislelizumab (PD-1 inhibitor)
  • Long-course chemoradiation, without Tislelizumab (PD-1 inhibitor)
  • Beijing, Beijing, China
    Beijing Friendship Hospital, Capital Medical University
Apr 25, 2023

Esophageal Squamous Cell Carcinoma Trial in Tianjin (biological, drug, radiation)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Pembrolizumab
  • +3 more
  • Tianjin, Tianjin, China
    Department of minimally invasive esophageal surgery, Tianjin Med
May 26, 2022

Nasopharyngeal Carcinoma, Nasopharyngeal Cancer Trial in China (Cadonilimab, Gemcitabine, Cisplatin)

Not yet recruiting
  • Nasopharyngeal Carcinoma
  • Nasopharyngeal Cancer
  • Bengbu, Anhui, China
  • +12 more
Dec 13, 2022

Nasopharyngeal Carcinoma Trial in Beijing (Tislelizumab)

Recruiting
  • Nasopharyngeal Carcinoma
  • Beijing, Beijing, China
    National Cancer Center /National Clinical Research Center for Ca
Jul 4, 2022

Esophageal Squamous Cell Carcinoma Trial in Shanghai (Nivolumab, Cisplatin, Paclitaxel)

Recruiting
  • Esophageal Squamous Cell Carcinoma
  • Shanghai, China
    180 Fenglin Road
Jun 12, 2022

Limited Stage Small Cell Lung Cancer Trial in Guangzhou (Sugemalimab, Placebo)

Not yet recruiting
  • Limited Stage Small Cell Lung Cancer
  • Guangzhou, Guangdong, China
    Sun Yat-sen University Cancer Center
Nov 12, 2022